Murray Stahl's AZN Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 5,497 shares of AstraZeneca PLC (AZN) worth $1.01 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 13,000 shares. Largest reduction occurred in Q3 2015, reducing 12,000 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -241 | Reduce 4.20% | 5,497 | $183.86 |
| Q3 2025 | -238 | Reduce 3.98% | 5,738 | $153.44 |
| Q2 2025 | -452 | Reduce 7.03% | 5,976 | $139.76 |
| Q1 2025 | -10 | Reduce 0.16% | 6,428 | $147.00 |
| Q4 2024 | +261 | Add 4.23% | 6,438 | $131.04 |
| Q3 2024 | -308 | Reduce 4.75% | 6,177 | $155.82 |
| Q2 2024 | -218 | Reduce 3.25% | 6,485 | $155.98 |
| Q1 2024 | +1 | Add 0.01% | 6,703 | $135.50 |
| Q4 2023 | -287 | Reduce 4.11% | 6,702 | $134.70 |
| Q3 2023 | -40 | Reduce 0.57% | 6,989 | $135.44 |
| Q4 2022 | -517 | Reduce 6.85% | 7,029 | $135.60 |
| Q3 2022 | +17 | Add 0.23% | 7,546 | $109.73 |
| Q2 2022 | -103 | Reduce 1.35% | 7,529 | $132.16 |
| Q2 2021 | -2,000 | Reduce 20.76% | 7,632 | $119.76 |
| Q4 2020 | -1,000 | Reduce 9.41% | 9,632 | $99.98 |
| Q1 2020 | -2,000 | Reduce 15.83% | 10,632 | $89.35 |
| Q3 2018 | -1,000 | Reduce 7.34% | 12,632 | $79.16 |
| Q2 2018 | -1,610 | Reduce 10.56% | 13,632 | $70.20 |
| Q1 2018 | -300 | Reduce 1.93% | 15,242 | $69.94 |
| Q4 2017 | -81 | Reduce 0.52% | 15,542 | $69.36 |
| Q3 2017 | +1,354 | Add 9.49% | 15,623 | $67.72 |
| Q2 2017 | +118 | Add 0.83% | 14,269 | $68.19 |
| Q1 2016 | +151 | Add 1.08% | 14,151 | $56.32 |
| Q3 2015 | -12,000 | Reduce 46.15% | 14,000 | $63.64 |
| Q2 2015 | +13,000 | Add 100.00% | 26,000 | $31.85 |
| Q2 2014 | -106 | Reduce 0.81% | 13,000 | $74.31 |
| Q1 2014 | +1,086 | Add 9.03% | 13,106 | $64.86 |
| Q3 2013 | +20 | Add 0.17% | 12,020 | $51.91 |
| Q2 2013 | +24,002 | Add 0.00% | 12,000 | $47.33 |
Murray Stahl's AstraZeneca PLC Investment FAQs
Murray Stahl first purchased AstraZeneca PLC (AZN) in Q2 2013, acquiring 12,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held AstraZeneca PLC (AZN) for 51 quarters since Q2 2013.
Murray Stahl's largest addition to AstraZeneca PLC (AZN) was in Q2 2013, adding 12,000 shares worth $568,000.
According to the latest 13F filing for Q4 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 5,497 shares of AstraZeneca PLC (AZN), valued at approximately $1.01 M.
As of the Q4 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.01% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in AstraZeneca PLC (AZN) was 26,000 shares, as reported at the end of Q2 2015.